Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Jan 27, 2022; 14(1): 24-35
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.24
Published online Jan 27, 2022. doi: 10.4240/wjgs.v14.i1.24
Table 1 Clinical, laboratory and operative patient characteristics (n = 83)
Clinical, laboratory and operative patient characteristics (n = 83) | |
Age (yr), median (IQR) | 59 (49–67) |
Sex, male/female, n (%) | 36 (43)/47 (57) |
Perioperative transfusion, n (%) | 21 (25) |
Haemoglobin in g/L, median (IQR) | 115 (108–127) |
Platelet count in 109/L, median (IQR) | 285 (243–372) |
International Normalized Ratio, median (IQR) | 1.06 (1.01–1.15) |
Serum glucose in mmol/L, median (IQR) | 5.1 (4.8–5.7) |
Serum creatinine in mmol/L, median (IQR) | 53 (47–65) |
Serum albumin in g/L, median (IQR) | 38.1 (32–41.1) |
Serum total bilirubin in µmol/L, median (IQR) | 23.9 (12.9–60) |
Serum CA 19-9 in IU/mL, median (IQR) | 26.3 (10–91.4) |
Pancreaticoduodenectomy | |
Pylorus-preserving PD, n (%) | 69 (83) |
Whipple procedure, n (%) | 14 (17) |
Table 2 Histopathologic characteristics (n = 83)
Histopathologic characteristics (n = 83) | |
Tumour size in mm, median (IQR) | 27 (17–40) |
Subtype, n (%) | |
Intestinal | 57 (69) |
Pancreatobiliary | 19 (23) |
Others | 7 (8) |
Tumour status, n (%) | |
T1 | 7 (8) |
T2 | 44 (53) |
T3 | 32 (39) |
Number of lymph nodes assessed, median (IQR) | 17 (12–24) |
Lymph node status, n (%) | |
N0 | 50 (60) |
N1 | 22 (26) |
N2 | 11 (14) |
Differentiation, n (%) | |
Well differentiated | 25 (30) |
Moderately differentiated | 53 (64) |
Poorly differentiated | 5 (6) |
Lymphovascular invasion | 30 (36) |
Perineural invasion | 26 (31) |
Table 3 Recurrence patterns after pancreaticoduodenectomy (n = 19)
Organs involved | |||||
Distant metastasis, n (%) | (A) First organ | (B) Second organ | (C) Third organ | A + B + C | % |
Liver | 8 | 3 | 1 | 12 | 32 |
Peritoneum | 4 | 3 | 1 | 8 | 22 |
Lung | 4 | 2 | 1 | 7 | 19 |
Supraclavicular lymph node | 1 | 1 | 3 | ||
Bone | 1 | 1 | 3 | ||
Suprarenal gland | 1 | 1 | 3 | ||
Sub-table total | 30 | 81 | |||
Lymph nodal recurrence, n (%) | |||||
Celiac trunk | 1 | 1 | 3 | ||
Hepatic hilum | 1 | 1 | 3 | ||
Mesenteric lymph nodes | 1 | 1 | 2 | 5 | |
Retroperitoneal lymph nodes | 2 | 1 | 3 | 8 | |
Sub-table total | 7 | 19 | |||
Total | 37 | 100 |
Table 4 Cox regression model analysis for predictors of overall survival
Variables | Hazard ratio | 95%CI | P value | |
Lower | Upper | |||
Age in yr | 0.355 | |||
Tumour size in mm | 1.03 | 1 | 1.06 | 0.059 |
Histopathologic subtype | ||||
Intestinal/other types | ||||
Pancreatobiliary type | 2.7 | 1.2 | 6.2 | 0.025 |
T classification | ||||
T1-T2 | ||||
T3 | 6.4 | 2.5 | 16.3 | < 0.001 |
Lymph node metastasis | ||||
No | ||||
Yes | 4.5 | 1.8 | 11.3 | 0.001 |
Differentiation grade | 0.54 | |||
Well differentiated | ||||
Moderately differentiated | 0.268 | |||
Poorly differentiated | 0.755 | |||
Perineural invasion | 0.517 | |||
Lymphovascular invasion | 0.26 |
- Citation: Fernandez-Placencia RM, Montenegro P, Guerrero M, Serrano M, Ortega E, Bravo M, Huanca L, Bertani S, Trejo JM, Webb P, Malca-Vasquez J, Taxa L, Lachos-Davila A, Celis-Zapata J, Luque-Vasquez C, Payet E, Ruiz E, Berrospi F. Survival after curative pancreaticoduodenectomy for ampullary adenocarcinoma in a South American population: A retrospective cohort study. World J Gastrointest Surg 2022; 14(1): 24-35
- URL: https://www.wjgnet.com/1948-9366/full/v14/i1/24.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i1.24